ライフサイエンスコーパス: arteriovenous malformation

1 s with pituitary tumor, medulloblastoma, and arteriovenous malformation.

2 nt feeding artery, which was consistent with arteriovenous malformation.

3 mab to treat the macular oedema in a case of arteriovenous malformation.

4 ted] as assessed by development of pulmonary arteriovenous malformation.

5 pared with those presenting with hemorrhagic arteriovenous malformation.

6 emorrhage after embolization of a cerebellar arteriovenous malformation.

7 in 18 patients with head and neck tumors and arteriovenous malformations.

8 well as the presence of multiple and massive arteriovenous malformations.

9 on congenital heart disease and intracranial arteriovenous malformations.

10 ular assist devices (LVADs) and is caused by arteriovenous malformations.

11 ication of nascent blood vessels and develop arteriovenous malformations.

12 , congestive heart failure due to a cerebral arteriovenous malformation (1), tracheal occlusion incur

13 Treatment for arteriovenous malformations aims to prevent and resolve

14 ovascular accident caused by a right pontine arteriovenous malformation and destruction of the right

15 Mice mutant for Notch1 and Notch3 develop arteriovenous malformations and display hallmarks of the

16 In arteriovenous malformations and dural arteriovenous fist

17 f some other conditions, such as parenchymal arteriovenous malformations and intracerebral hemorrhage

18 y related Fox transcription factors, exhibit arteriovenous malformations and lack of induction of art

19 ed by the age-dependent development of focal arteriovenous malformations and telangiectases.

20 Defects in the hyaloid vasculature, arteriovenous malformations, and coarctation of the aort

21 terized by multisystemic vascular dysplasia, arteriovenous malformations, and focal dilatation of pos

22 chronic obstructive pulmonary disease, brain arteriovenous malformations, and select cancers.

23 estigate the proper management of unruptured arteriovenous malformations, and the key factors in endo

24 Brain arteriovenous malformations are currently attracting inc

25 A Randomised trial of Unruptured Brain Arteriovenous malformations (ARUBA) aims to compare the

26 el density was comparable for hemangioma and arteriovenous malformation (AVM) but significantly great

27 n about whether to treat an unruptured brain arteriovenous malformation (AVM) depends on a comparison

28 Congenital arteriovenous malformation (AVM) in the pelvic area is u

29 Arteriovenous malformation (AVM) is a fast-flow, congeni

30 A uterine arteriovenous malformation (AVM) is a rare cause of uter

31 Arteriovenous malformation (AVM) is an abnormal connecti

32 entation of intracranial hemorrhage in brain arteriovenous malformation (AVM) patients.

33 This arteriovenous malformation (AVM), which shunts nearly al

34 better outcome prediction for patients with arteriovenous malformation (AVM)-related intracerebral h

35 As brain arteriovenous malformations (AVM) and intracranial aneur

36 proportion of strokes are caused by cerebral arteriovenous malformations (AVM).

37 epistaxis, mucocutaneous telangiectases, and arteriovenous malformations (AVM).

38 Brain arteriovenous malformations (AVMs) are an important caus

39 Cerebral arteriovenous malformations (AVMs) are common vascular m

40 Brain arteriovenous malformations (AVMs) are currently being t

41 Arteriovenous malformations (AVMs) are fragile direct co

42 Extracranial arteriovenous malformations (AVMs) are rare but dangerou

43 Arteriovenous malformations (AVMs) are tortuous vessels

44 Pelvic arteriovenous malformations (AVMs) are uncommon lesions

45 Arteriovenous malformations (AVMs) are vascular anomalie

46 Spinal arteriovenous malformations (AVMs) can lead to developme

47 Arteriovenous malformations (AVMs) in organs, such as th

48 age (ICH) for patients with unruptured brain arteriovenous malformations (AVMs) in the natural course

49 n about the frequency and clinical course of arteriovenous malformations (AVMs) of the brain in adult

50 Because mutations in ALK1 cause arteriovenous malformations (AVMs), our findings suggest

51 characterized by excessive angiogenesis with arteriovenous malformations (AVMs).

52 t connections between arteries and veins, or arteriovenous malformations (AVMs).

53 es to life-threatening visceral and cerebral arteriovenous malformations (AVMs).

54 l hypervascularization and the appearance of arteriovenous malformations (AVMs).

55 after stereotactic radiosurgery for cerebral arteriovenous malformations (AVMs).

56 g capillary beds is the primary pathology of arteriovenous malformations (AVMs).

57 Brain arteriovenous malformations (BAVMs) are a rare but poten

58 Brain arteriovenous malformations (bAVMs) are an important cau

59 Brain arteriovenous malformations (BAVMs) are congenital vascu

60 Brain arteriovenous malformations (BAVMs) can cause devastatin

61 nterventional treatment for unruptured brain arteriovenous malformations (bAVMs) is uncertain because

62 The pathogenesis of sporadic brain arteriovenous malformations (BAVMs) remains unknown, but

63 cally associated with capillary malformation-arteriovenous malformation, but sporadic reports of lymp

64 s achieved satisfactory obliteration of deep arteriovenous malformations, but with increased actuaria

65 Congenital heart diseases with arteriovenous malformations carry a high risk of mortali

66 The wide scope of pathology, including arteriovenous malformations, cavernous malformations and

67 Capillary malformation-arteriovenous malformation (CM-AVM) is a blood and lymph

68 Capillary malformation-arteriovenous malformation (CM-AVM) is an autosomal domi

69 RASA1 mutations cause capillary malformation-arteriovenous malformation (CM-AVM); whether it also fun

70 rhage, including age at initial diagnosis of arteriovenous malformation, co-existing extranidal aneur

71 Some arteriovenous malformations considered inoperable in the

72 Tissue samples from patients with arteriovenous malformations displayed strong endothelial

73 This review focuses on new concepts in arteriovenous malformation etiology, classification, tre

74 or stroke in patients with unruptured brain arteriovenous malformations followed up for 33 months.

75 Ang-2 therefore may contribute to arteriovenous malformation formation and subsequent blee

76 n the international, multicentre Genetics of Arteriovenous Malformation (GEN-AVM) consortium.

77 Pulmonary arteriovenous malformation has been traditionally diagno

78 Finally, many reports of recurrent arteriovenous malformations have coincided with new theo

79 data regarding factors associated with brain arteriovenous malformation hemorrhage and different trea

80 al and genetic factors associated with brain arteriovenous malformation hemorrhage, as well as studie

81 reatment options in patients with unruptured arteriovenous malformation in the future.

82 ges but with concerns about the formation of arteriovenous malformation in the lung excluded from hep

83 c tracheal connections that resemble certain arteriovenous malformations in humans.

84 emorrhagic telangiectasia, especially occult arteriovenous malformations in visceral organs that may

85 ing effective multidisciplinary treatment of arteriovenous malformations, including those previously

86 This resulted in defective angiogenesis and arteriovenous malformations, leading to embryonic lethal

87 moptysis caused by thoracic vascular injury, arteriovenous malformation, leaking thoracic aneurysm wi

88 tracranial stenosis, intracranial aneurysms, arteriovenous malformations, malignant gliomas, and meni

89 Two recent studies in unruptured brain arteriovenous malformation management - ARUBA (a multice

90 dy, 18 patients with tumors (n = 14), facial arteriovenous malformations (n = 3), and vertebral arter

91 Arteriovenous malformations of the brain (AMB) can cause

92 Arteriovenous malformations of the brain are congenital

93 Final histology showed that 2 patients had arteriovenous malformations: one had a benign hemangioma

94 ow in the setting of a previously unruptured arteriovenous malformation or aneurysm.

95 Known arteriovenous malformations or aneurysms are considered

96 No congenital arteriovenous malformations or congenital aneurysms demo

97 Future studies are needed to identify arteriovenous malformation patients at the greatest risk

98 tural course, and treatment outcome in adult arteriovenous malformation patients.

99 pulmonary angiography in detecting pulmonary arteriovenous malformation (PAVM) in children with cavop

100 We report on a case of pancreatic arteriovenous malformation (PAVM) that obliterated short

101 Within the past decade, pulmonary arteriovenous malformations (PAVMs) have evolved from ra

102 ss is a recognized complication of pulmonary arteriovenous malformations (PAVMs) that allow systemic

103 Renal arteriovenous malformation (RAVM) is a rare disease.

104 The recently published arteriovenous malformation-related intracerebral haemorr

105 f preventive eradication of unruptured brain arteriovenous malformations remains uncertain.

106 These mice die by mid-gestation with severe arteriovenous malformations resulting from fusion of maj

107 cyclines to decrease the rate of spontaneous arteriovenous malformation rupture.

108 areful angiographic assessment of individual arteriovenous malformations should be performed before e

109 A1-related disorders (capillary malformation-arteriovenous malformation syndrome).

110 ability, progressive cyanosis from pulmonary arteriovenous malformations, systemic to hepatic venoven

111 angiodysplastic lesions (telangiectases and arteriovenous malformations) that affect many organs.

112 st the hypothesis that, for unruptured brain arteriovenous malformations, there is no difference betw

113 a lipomatous mass, an epidermoid naevus and arteriovenous malformation tissue, all of which were sam

114 levant for understanding the causes of human arteriovenous malformations, tumor angiogenesis, and dia

115 ing to a diagnosis of capillary malformation/arteriovenous malformation type 1.

116 hese conditions include renal hemangiomas or arteriovenous malformations, ureteropelvic junction obst

117 ients (>/=18 years) with an unruptured brain arteriovenous malformation were enrolled into this trial

118 Patients with unruptured arteriovenous malformations were found to be more suscep

119 ), the hallmark vascular lesion is termed an arteriovenous malformation, which involves the direct co

120 stroke in patients with an unruptured brain arteriovenous malformation who are allocated to either m

121 n 21 subjects with epilepsy, brain tumor, or arteriovenous malformation who had undergone IAP and MEG

122 icentre randomized trial of unruptured brain arteriovenous malformations) will be of major importance